Inside Lilly’s $50bn push to transform American drug production
Eli Lilly and Company (Lilly) has unveiled an ambitious plan to more than double its U.S. manufacturing investment, committing over $50 billion since 2020. This ... Read More
Eli Lilly sets 2024 revenue at $45bn amid revised guidance
Eli Lilly and Company, a leading global pharmaceutical firm, has adjusted its 2024 revenue forecast to $45 billion, marking a 32% increase from the previous ... Read More
Lilly launches $4.5bn medicine foundry to reshape drug production and clinical trials
Eli Lilly and Company has committed $4.5 billion to establish a revolutionary facility in Lebanon, Indiana—the Lilly Medicine Foundry. This one-of-a-kind site is set to ... Read More
Lilly to invest $2.1bn in two new pharma manufacturing plants in Indiana
Eli Lilly and Company (Lilly) said that it will invest $2.1 billion to build two new pharma manufacturing plants in Indiana, which will be located ... Read More
FDA grants emergency use authorization for Bamlanivimab to treat Covid-19
The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for bamlanivimab (LY-CoV555), a neutralizing antibody developed by Eli Lilly and Company ... Read More
Lilly secures $375m deal with US govt for bamlanivimab Covid-19 treatment
Eli Lilly and Company (Lilly), a global pharmaceutical leader, has signed a significant $375 million agreement with the US government for the supply of 300,000 ... Read More
Lilly to build $470m pharma manufacturing plant in North Carolina
US pharma giant Eli Lilly and Company (Lilly) will build a new pharma manufacturing plant in North Carolina with an investment of more than $470 ... Read More